000			01623 a2200445 4500
005			20250513234943.0
264		0	_c20010503
008			200105s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm000491y _2doi
040			_aNLM _beng _cNLM
100	1		_aChambers, J J
245	0	0	_aEnantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists. _h[electronic resource]
260			_bJournal of medicinal chemistry _cMar 2001
300			_a1003-10 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a3T3 Cells
650	0	4	_aAlanine _xanalogs & derivatives
650	0	4	_aAmphetamines _xchemical synthesis
650	0	4	_aAnimals
650	0	4	_aBinding, Competitive
650	0	4	_aFurans _xchemical synthesis
650	0	4	_aHydrolysis
650	0	4	_aInositol Phosphates _xmetabolism
650	0	4	_aLigands
650	0	4	_aMice
650	0	4	_aMolecular Conformation
650	0	4	_aRadioligand Assay
650	0	4	_aRats
650	0	4	_aReceptor, Serotonin, 5-HT2A
650	0	4	_aReceptor, Serotonin, 5-HT2C
650	0	4	_aReceptors, Serotonin _xdrug effects
650	0	4	_aSerotonin Receptor Agonists _xchemical synthesis
650	0	4	_aStereoisomerism
700	1		_aKurrasch-Orbaugh, D M
700	1		_aParker, M A
700	1		_aNichols, D E
773	0		_tJournal of medicinal chemistry _gvol. 44 _gno. 6 _gp. 1003-10
856	4	0	_uhttps://doi.org/10.1021/jm000491y _zAvailable from publisher's website
999			_c11235820 _d11235820